Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease

被引:25
作者
Mango, Robert L. [1 ]
Matteson, Eric L. [1 ,2 ]
Crowson, Cynthia S. [1 ,2 ]
Ryu, Jay H. [3 ]
Makol, Ashima [1 ,4 ]
机构
[1] Mayo Clin Coll Med & Sci, Div Rheumatol, Rochester, MN 55905 USA
[2] Mayo Clin Coll Med & Sci, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin Coll Med & Sci, Div Pulm & Crit Care Med, Rochester, MN USA
[4] Mayo Clin, Dept Internal Med, Div Rheumatol, 200 1st St SW, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Systemic sclerosis; Interstitial lung disease; Non-specific interstitial pneumonia; Usual interstitial pneumonia; Mortality modeling; IDIOPATHIC PULMONARY-FIBROSIS; SCLERODERMA LUNG; RISK PREDICTION; STAGING SYSTEM; SURVIVAL; TRIALS; SMOKING; PLACEBO; TRENDS; COHORT;
D O I
10.1007/s00408-018-0126-6
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The gender, age, and lung physiology (GAP) model, interstitial lung diseases-GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung (SADL) model were compared using a systemic sclerosis-ILD (SSc-ILD) cohort to evaluate which best determined prognosis. The models were applied to a cohort of 179 patients with SSc seen at a tertiary care center within 1 year of ILD diagnosis. Demographics, clinical characteristics, and mortality were recorded. The performance of the models was assessed using standardized mortality ratios (SMR) of observed versus predicted outcomes for calibration and concordance (c)-statistics for discrimination. SSc-ILD patients with usual interstitial pneumonia (31, 17%) had a higher mortality than those with non-specific interstitial pneumonia (147, 83%) (hazard ratio 2.27; 95%CI 1.03-4.97). All 3 models had comparable discrimination (c = 0.72, 0.72, and 0.71, respectively). Regarding calibration, the ILD-GAP model underestimated mortality (SMR 1.50; 95%CI 1.05-2.14). Calibration was acceptable for SADL (SMR 1.00; 95%CI 0.70-1.44) and GAP (SMR 0.90; 95%CI 0.63-1.29). The SADL model underestimated mortality in Stage I ILD. The ILD-GAP model underestimated mortality, and the SADL model underestimated mortality in certain subgroups. However, the GAP model performed well in this cohort, providing the best prognostic information for SSc-ILD.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 32 条
[11]   Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies [J].
Elhai, Muriel ;
Meune, Christophe ;
Avouac, Jerome ;
Kahan, Andre ;
Allanore, Yannick .
RHEUMATOLOGY, 2012, 51 (06) :1017-1026
[12]   Clinically significant interstitial lung disease in limited scleroderma - Histopathology, clinical features, and survival [J].
Fischer, Aryeh ;
Swigris, Jeffrey J. ;
Groshong, Steve D. ;
Cool, Carlyne D. ;
Sahin, Hakan ;
Lynch, David A. ;
Curran-Everett, Douglas ;
Gillis, JoAnn Z. ;
Meehan, Richard T. ;
Brown, Kevin K. .
CHEST, 2008, 134 (03) :601-605
[13]   Radiological versus histological diagnosis in UIP and NSIP: survival implications [J].
Flaherty, KR ;
Thwaite, EL ;
Kazerooni, EA ;
Gross, BH ;
Toews, GB ;
Colby, TV ;
Travis, WD ;
Mumford, JA ;
Murray, S ;
Flint, A ;
Lynch, JP ;
Martinez, FJ .
THORAX, 2003, 58 (02) :143-148
[14]   Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis [J].
Goh, Nicole S. ;
Hoyles, Rachel K. ;
Denton, Christopher P. ;
Hansell, David M. ;
Renzoni, Elisabetta A. ;
Maher, Toby M. ;
Nicholson, Andrew G. ;
Wells, Athol U. .
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (08) :1670-1678
[15]   Interstitial lung disease in systemic sclerosis - A simple staging system [J].
Goh, Nicole S. L. ;
Desai, Sujai R. ;
Veeraraghavan, Srihari ;
Hansell, David M. ;
Copley, Susan J. ;
Maher, Toby M. ;
Corte, Tarnera J. ;
Sander, Clare R. ;
Ratoff, Jonathan ;
Devaraj, Anand ;
Bozovic, Gracijela ;
Denton, Christopher P. ;
Black, Carol M. ;
du Bois, Roland M. ;
Wells, Athol U. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (11) :1248-1254
[16]   Cigarette smoking in patients with systemic sclerosis reduces overall survival: comment on the article by Hudson et al [J].
Hissaria, P. ;
Roberts-Thomson, P. J. ;
Lester, Sue ;
Ahern, M. J. ;
Smith, M. D. ;
Walker, J. G. .
ARTHRITIS AND RHEUMATISM, 2011, 63 (06) :1758-1759
[17]   Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group [J].
Khanna, Dinesh ;
Mittoo, Shikha ;
Aggarwal, Rohit ;
Proudman, Susanna M. ;
Dalbeth, Nicola ;
Matteson, Eric L. ;
Brown, Kevin ;
Flaherty, Kevin ;
Wells, Athol U. ;
Seibold, James R. ;
Strand, Vibeke .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (11) :2168-2171
[18]   Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials [J].
Lee, Joyce S. ;
Collard, Harold R. ;
Anstrom, Kevin J. ;
Martinez, Fernando J. ;
Noth, Imre ;
Roberts, Rhonda S. ;
Yow, Eric ;
Raghu, Ganesh .
LANCET RESPIRATORY MEDICINE, 2013, 1 (05) :369-376
[19]   A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis [J].
Ley, Brett ;
Ryerson, Christopher J. ;
Vittinghoff, Eric ;
Ryu, Jay H. ;
Tomassetti, Sara ;
Lee, Joyce S. ;
Poletti, Venerino ;
Buccioli, Matteo ;
Elicker, Brett M. ;
Jones, Kirk D. ;
King, Talmadge E., Jr. ;
Collard, Harold R. .
ANNALS OF INTERNAL MEDICINE, 2012, 156 (10) :684-U58
[20]   Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease The SADL Model [J].
Morisset, Julie ;
Vittinghoff, Eric ;
Elicker, Brett M. ;
Hu, Xiaowen ;
Le, Stephanie ;
Ryu, Jay H. ;
Jones, Kirk D. ;
Haemel, Anna ;
Golden, Jeffrey A. ;
Boin, Francesco ;
Ley, Brett ;
Wolters, Paul J. ;
King, Talmadge E., Jr. ;
Collard, Harold R. ;
Lee, Joyce S. .
CHEST, 2017, 152 (05) :999-1007